• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » It’s three for three for Phase Forward as it inks yet another deal

It’s three for three for Phase Forward as it inks yet another deal

November 5, 2009 By MassDevice staff

It’s another day, another deal for Phase Forward Inc., which announced a multi-year deal with Quotient Clinical.

Quotient Clinical, a subsidiary of U.K.-based Quotient Bioresearch, provides early support services for biotechnology and pharmaceutical firms, including proof-of-concept and first-in-human trials. The deal calls for Quotient Clinicial to implement the Waltham, Mass.-based data management provider’s clinical trial management and data capture software. Financial terms were not disclosed.

The agreement marks the third contract for Phase Forward in as many days. The company signed a deal with clinical trial services provider PharmaNet Development Group Inc. Nov. 4 and a pact with the Food & Drug Administration Nov. 2.

That makes for heady days for Phase Forward, which sits in a shiny new office tower on 4th Street in Waltham, overlooking I-95 and the Cambridge Reservoir. Last week the company beat Wall Street’s expectations with its third-quarter results, posting net earnings of $1.2 million on $53 million in sales.

During a conference call with analysts, CEO Bob Weiler said there appeared to be a modest surge underway in funding for biotech companies, portending a restart of clinical trials now shelved at development-stage firms. He suggested a potential jump in business from larger pharmaceutical companies — many of which will have blockbuster drugs coming off patents during the next few years.

Filed Under: Business/Financial News Tagged With: Data Management

More recent news

  • Real-world data backs Route 92 reperfusion system
  • LivsMed unveils new surgical robot with telesurgery capabilities
  • JenaValve enrolls first patient in TAVR for AR study
  • HistoSonics expands insurance coverage for histotripsy treatment
  • Johnson & Johnson MedTech gets updated FDA nod for Varipulse PFA

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy